Figure 10.
Glucose-lowering effect and pharmacodynamic profile of PEG-BHD1028 following s.c. administration of 50, 100, and 200 μg/Kg PEG-BHD1028 in db/db mice (n = 5/group). ** p ≤ 0.01, * p ≤ 0.05 vs. control.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.